rs61749665

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BS2BA1BP4

This summary comes from the ClinGen Evidence Repository: The NM_000180.4(GUCY2D):c.154G>T (p.Ala52Ser) variant is predicted to replace the alanine at position p.52 with serine. This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.6857, with 26306 alleles / 37974 total alleles in the East Asian population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in 95,479 adult individuals in gnomAD v4.1.0 (BS2). The computational predictor REVEL gives a score of 0.126, which is below the ClinGen LCA / eoRD VCEP threshold of ≤0.183 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0.0, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4_Moderate). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BS2, BP4_Moderate. (VCEP specifications version 1.0.0; date of approval 01/22/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA145842/MONDO:0100453/167

Frequency

Genomes: 𝑓 0.31 ( 8439 hom., cov: 33)
Exomes 𝑓: 0.34 ( 87040 hom. )

Consequence

GUCY2D
NM_000180.4 missense

Scores

1
17

Clinical Significance

Benign reviewed by expert panel P:1B:15O:1

Conservation

PhyloP100: -0.508

Publications

24 publications found
Variant links:
Genes affected
GUCY2D (HGNC:4689): (guanylate cyclase 2D, retinal) This gene encodes a retina-specific guanylate cyclase, which is a member of the membrane guanylyl cyclase family. Like other membrane guanylyl cyclases, this enzyme has a hydrophobic amino-terminal signal sequence followed by a large extracellular domain, a single membrane spanning domain, a kinase homology domain, and a guanylyl cyclase catalytic domain. In contrast to other membrane guanylyl cyclases, this enzyme is not activated by natriuretic peptides. Mutations in this gene result in Leber congenital amaurosis and cone-rod dystrophy-6 diseases. [provided by RefSeq, Dec 2008]
GUCY2D Gene-Disease associations (from GenCC):
  • cone-rod dystrophy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • GUCY2D-related dominant retinopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • GUCY2D-related recessive retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Leber congenital amaurosis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • night blindness, congenital stationary, type1i
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • central areolar choroidal dystrophy
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GUCY2DNM_000180.4 linkc.154G>T p.Ala52Ser missense_variant Exon 2 of 20 ENST00000254854.5 NP_000171.1 Q02846
GUCY2DXM_011523816.2 linkc.154G>T p.Ala52Ser missense_variant Exon 1 of 19 XP_011522118.1 Q02846

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GUCY2DENST00000254854.5 linkc.154G>T p.Ala52Ser missense_variant Exon 2 of 20 1 NM_000180.4 ENSP00000254854.4 Q02846

Frequencies

GnomAD3 genomes
AF:
0.311
AC:
47231
AN:
151842
Hom.:
8437
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.341
Gnomad AMR
AF:
0.384
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.679
Gnomad SAS
AF:
0.584
Gnomad FIN
AF:
0.411
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.319
Gnomad OTH
AF:
0.312
GnomAD2 exomes
AF:
0.416
AC:
46515
AN:
111840
AF XY:
0.426
show subpopulations
Gnomad AFR exome
AF:
0.182
Gnomad AMR exome
AF:
0.434
Gnomad ASJ exome
AF:
0.332
Gnomad EAS exome
AF:
0.695
Gnomad FIN exome
AF:
0.402
Gnomad NFE exome
AF:
0.312
Gnomad OTH exome
AF:
0.356
GnomAD4 exome
AF:
0.345
AC:
470659
AN:
1365212
Hom.:
87040
Cov.:
36
AF XY:
0.351
AC XY:
236627
AN XY:
673498
show subpopulations
African (AFR)
AF:
0.158
AC:
4415
AN:
28014
American (AMR)
AF:
0.429
AC:
14459
AN:
33690
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
7952
AN:
24230
East Asian (EAS)
AF:
0.695
AC:
22838
AN:
32864
South Asian (SAS)
AF:
0.579
AC:
44239
AN:
76354
European-Finnish (FIN)
AF:
0.404
AC:
15500
AN:
38390
Middle Eastern (MID)
AF:
0.324
AC:
1452
AN:
4476
European-Non Finnish (NFE)
AF:
0.317
AC:
339518
AN:
1070330
Other (OTH)
AF:
0.357
AC:
20286
AN:
56864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
15412
30825
46237
61650
77062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11422
22844
34266
45688
57110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.311
AC:
47235
AN:
151950
Hom.:
8439
Cov.:
33
AF XY:
0.323
AC XY:
24004
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.166
AC:
6875
AN:
41508
American (AMR)
AF:
0.384
AC:
5865
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1167
AN:
3468
East Asian (EAS)
AF:
0.679
AC:
3468
AN:
5110
South Asian (SAS)
AF:
0.582
AC:
2808
AN:
4822
European-Finnish (FIN)
AF:
0.411
AC:
4347
AN:
10564
Middle Eastern (MID)
AF:
0.318
AC:
93
AN:
292
European-Non Finnish (NFE)
AF:
0.319
AC:
21633
AN:
67892
Other (OTH)
AF:
0.317
AC:
670
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1607
3215
4822
6430
8037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
2204
Bravo
AF:
0.297
TwinsUK
AF:
0.318
AC:
1179
ALSPAC
AF:
0.328
AC:
1264
ESP6500AA
AF:
0.126
AC:
396
ESP6500EA
AF:
0.243
AC:
1601
ExAC
AF:
0.295
AC:
22211
Asia WGS
AF:
0.596
AC:
2061
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:15Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:6
Mar 16, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4Other:1
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1;C4551884:Choroidal dystrophy, central areolar, 1;C5231408:Night blindness, congenital stationary, type1i Benign:2
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 24, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Leber congenital amaurosis 1 Pathogenic:1
Aug 01, 1998
OMIM
Significance:Pathogenic
Review Status:flagged submission
Collection Method:literature only

- -

Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GUCY2D-related recessive retinopathy Benign:1
Jan 30, 2025
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The NM_000180.4(GUCY2D):c.154G>T (p.Ala52Ser) variant is predicted to replace the alanine at position p.52 with serine. This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.6857, with 26306 alleles / 37974 total alleles in the East Asian population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in 95,479 adult individuals in gnomAD v4.1.0 (BS2). The computational predictor REVEL gives a score of 0.126, which is below the ClinGen LCA / eoRD VCEP threshold of ≤0.183 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0.0, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4_Moderate). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BS2, BP4_Moderate. (VCEP specifications version 1.0.0; date of approval 01/22/2025). -

Cone-rod dystrophy 6 Benign:1
Oct 04, 2021
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Population allele frequency is 40% (rs61749665, 54,832/138,790 alleles in gnomAD v2.0.2). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as Benign. Following criteria met: BA1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
2.0
DANN
Benign
0.86
DEOGEN2
Benign
0.12
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.36
T
MetaRNN
Benign
0.0000021
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.51
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.85
N
REVEL
Benign
0.13
Sift
Benign
0.20
T
Sift4G
Benign
0.28
T
Polyphen
0.17
B
Vest4
0.040
MPC
1.2
ClinPred
0.0024
T
GERP RS
0.19
Varity_R
0.052
gMVP
0.30
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61749665; hg19: chr17-7906519; COSMIC: COSV54695038; API